CPT® Code 86890

1. Indications

The procedure described by CPT® Code 86890 is indicated for patients who are scheduled to undergo surgical procedures or treatments that may require blood transfusion. The following conditions or situations may warrant the use of autologous blood collection:

• Elective Surgery: Patients undergoing elective surgeries where there is a potential for significant blood loss may benefit from having their own blood available for transfusion.
• History of Transfusion Reactions: Individuals with a history of adverse reactions to transfusions may opt for autologous blood to mitigate risks associated with allogeneic blood products.
• Increased Risk of Infection: Patients who are at a higher risk for infections may prefer autologous blood to avoid the potential transmission of infectious diseases from donor blood.
• Planned Procedures Requiring Blood: Any medical procedure that is anticipated to require blood transfusion, such as orthopedic surgeries, cardiac surgeries, or major abdominal surgeries, may indicate the need for this procedure.

2. Procedure

The procedure for CPT® Code 86890 involves several key steps to ensure the safe and effective collection, processing, and storage of autologous blood or its components:

• Step 1: Patient Assessment and Consent: Prior to the collection, the patient is assessed for hemodynamic stability and suitability for blood donation. Informed consent is obtained, ensuring the patient understands the procedure and its benefits.
• Step 2: Blood Collection: The patient donates blood, which can be collected in a clinical setting. The blood is drawn using standard venipuncture techniques and collected into sterile blood bags specifically designed for autologous use.
• Step 3: Processing: Once collected, the blood is processed to separate its components, such as red blood cells, leukocytes, and platelets. This may involve centrifugation to concentrate the desired components.
• Step 4: Storage: The processed blood components are then stored in appropriate conditions, typically at controlled temperatures, to maintain their viability until they are needed for transfusion.
• Step 5: Labeling: Each unit of blood or blood component is labeled specifically for the patient, ensuring that it is reserved for their use and not subject to the screening required for general blood supply.

3. Post-Procedure

After the collection and processing of autologous blood, patients are monitored for any adverse reactions to the donation. They may experience mild side effects such as dizziness or fatigue, which are typically transient. Patients are advised to hydrate and rest following the procedure. The stored blood components remain available for transfusion during the scheduled procedure, and the patient should be informed about the timing and process of transfusion should it be necessary. Regular follow-up may be required to ensure the patient’s health remains stable and to assess the need for additional donations if the procedure is scheduled further in the future.